Surmodics, Inc.
Surmodics, Inc.（SRDX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · SRDX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
1
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Surmodics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
SRDX 季度内部人买卖趋势
SRDX 内幕交易卖出 · SRDX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · SRDX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
SRDX 高管卖出股份 · SRDX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Nov 19, 2025 | OLSON CHARLES W SVP, Medical Device Coatings | Other | 800 | $40 | Form 4 |
| Nov 19, 2025 | Manders John D. VP Finance, Corp. Controller | Other | 8,155 | $408 | Form 4 |
| Nov 19, 2025 | Weber Gordon S. Sr. VP of Legal, GC and Sec. | Other | 21,040 | $1K | Form 4 |
| Nov 19, 2025 | SIDES TERI WOODWICK SVP, Vascular Interventions | Other | 34,703 | $2K | Form 4 |
| Nov 19, 2025 | DANTZKER DAVID Director | Other | 40,183 | $2K | Form 4 |
| Nov 19, 2025 | Heine Lisa Wipperman Director | Other | 13,978 | $699 | Form 4 |
| Nov 19, 2025 | KNIGHT SUSAN E Director | Other | 37,240 | $2K | Form 4 |
| Nov 19, 2025 | BEDOYA JOSE H Director | Other | 30,008 | $2K | Form 4 |
| Nov 19, 2025 | Arens Timothy J. CFO | Other | 67,299 | $3K | Form 4 |
| Nov 19, 2025 | Stich Joseph J. SVP of HR, President IVD | Other | 61,631 | $3K | Form 4 |
| Nov 19, 2025 | Maharaj Gary R President & CEO · Director | Other | 192,056 | $10K | Form 4 |
| Feb 18, 2025 | Heine Lisa Wipperman Director | Option | 2,640 | $72K | Form 4 |
| Feb 18, 2025 | Heine Lisa Wipperman Director | Other | 2,115 | $72K | Form 4 |
| Feb 13, 2025 | DANTZKER DAVID Director | Option | 5,275 | $144K | Form 4 |
| Feb 13, 2025 | DANTZKER DAVID Director | Other | 4,216 | $144K | Form 4 |
| Feb 14, 2025 | BEDOYA JOSE H Director | Option | 5,275 | $144K | Form 4 |
| Feb 14, 2025 | BEDOYA JOSE H Director | Other | 4,224 | $144K | Form 4 |
| Jan 24, 2025 | KNIGHT SUSAN E Director | Option | 7,358 | $201K | Form 4 |
| Jan 24, 2025 | KNIGHT SUSAN E Director | Other | 5,266 | $201K | Form 4 |
| Dec 4, 2024 | Arens Timothy J. CFO | Other | 1,265 | $50K | Form 4 |
| Dec 4, 2024 | Weber Gordon S. Sr. VP of Legal, GC and Sec. | Other | 668 | $27K | Form 4 |
| Dec 4, 2024 | SIDES TERI WOODWICK SVP, Vascular Interventions | Other | 946 | $38K | Form 4 |
| Dec 4, 2024 | Manders John D. VP Finance, Corp. Controller | Other | 152 | $6K | Form 4 |
| Dec 4, 2024 | Stich Joseph J. SVP of HR, President IVD | Other | 1,034 | $41K | Form 4 |
| Dec 4, 2024 | OLSON CHARLES W SVP, Medical Device Coatings | Other | 959 | $38K | Form 4 |
SIDES TERI WOODWICK
SVP, Vascular Interventions
日期
Nov 19
股数
34,703
均价
$0.05
总金额
$2K
SIDES TERI WOODWICK
SVP, Vascular Interventions
日期
Dec 4
股数
946
均价
$39.91
总金额
$38K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 SRDX 内幕交易
SRDX 内幕交易
Surmodics, Inc.（SRDX）内幕交易数据来源于公司内部人（包括OLSON CHARLES W (SVP, Medical Device Coatings), Manders John D. (VP Finance, Corp. Controller), Weber Gordon S. (Sr. VP of Legal, GC and Sec.)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。SRDX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Surmodics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
SRDX 内幕交易 · 5个问题Surmodics, Inc.（SRDX）的内部人包括高管和董事，如OLSON CHARLES W (SVP, Medical Device Coatings), Manders John D. (VP Finance, Corp. Controller), Weber Gordon S. (Sr. VP of Legal, GC and Sec.)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026